CRYSTAL MCBEE: Open Payments
NPI 1396373205 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,651 in 120 payments from 17 companies in 2025. Trend: 2023 $980 · 2024 $1,265 · 2025 $1,651
Food & beverage: $1,651
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $538 |
| Axsome Therapeutics, Inc. | 8 | $212 |
| Otsuka America Pharmaceutical, Inc. | 14 | $198 |
| Vanda Pharmaceuticals Inc. | 13 | $161 |
| Gilead Sciences, Inc. | 9 | $138 |
| Lundbeck LLC | 5 | $88 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Lilly USA, LLC | 2 | $31 |
Products named: VRAYLAR, REXULTI, Auvelity, MAVYRET, FANAPT, UBRELVY, HETLIOZ, QULIPTA.
Industry payments across OH — which companies pay providers there.
